Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3549492 Once Daily Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06683508 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT06683508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3549492 Once Daily Compared With Placebo in Adult Participants With Obesity or Overweight
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
November 13, 2024
Completion date
May 4, 2026
Enrollment
288 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight